Researchers reviewed existing literature on the effectiveness of several interventional oncological techniques developed to treat patients with metastatic liver disease. Currently complete surgical resection is considered the only curative treatment for metastatic liver disease, and these techniques
A team of researchers recently looked at the factors that influenced better overall survival (OS) and progression-free survival (PFS) following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma (HCC). The researchers analyzed 130 patients who underwent s
A new single-center prospective study set out to determine the prognostic significance of circulating tumor cells (CTCs) in patients with neuroendocrine cancer. In the study, 176 patients with measurable metastatic neuroendocrine tumors (NETs) were recruited. CTCs were measured using a semiautomated
One of the exciting developments in IO research has been the investment by industry in prospective clinical trials to help define best practice in the care of our patients. Nordion, Merit/Biosphere, Sirtex, BTG/Biocompatibles, Siemens, and Delcath all sponsor multicenter Phase 2 and 3 trials...